Private Wealth Management Group’s Immunovant IMVT Stock Holding History

Private Wealth Management Group’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.32K	Hold	128	–	–	﹤0.01%	942
2026 Q2	$4.93K	Hold	128	–	–	﹤0.01%	850
2026 Q1	$3.18K	Hold	128	–	–	﹤0.01%	926
2025 Q4	$3.25K	Hold	128	–	–	﹤0.01%	923
2025 Q3	$2.06K	Hold	128	–	–	﹤0.01%	1106
2025 Q2	$2.05K	Buy	128 +22	+21%	+$333	﹤0.01%	1078
2025 Q1	$1.81K	Buy	+106	New	+$2.22K	﹤0.01%	1088

Other funds holding IMVT

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.36% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Private Wealth Management Group's IMVT Position: Q3 2026 in Review

Private Wealth Management Group held its Immunovant (IMVT) position steady in Q3 2026 at 128 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

Private Wealth Management Group first reported a position in IMVT in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.93K in Q2 2026. 20 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

Private Wealth Management Group held 128 shares of Immunovant worth $4.32K as of Q3 2026.
Private Wealth Management Group left its Immunovant share count unchanged in Q3 2026.
Immunovant made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #942 holding.
Private Wealth Management Group first reported a position in Immunovant in Q1 2025 and has held it in 7 quarters since.
Private Wealth Management Group's Immunovant position peaked at $4.93K in Q2 2026.
20 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.